Hadassah

Hadassah and Hebrew University Discover Genetic Mutation that Prevents Ovary Development

Monday, Nov 16 2015

A picture of the ovarian cycle anatomy.

Scientists at the Hadassah Medical Center and Hebrew University have discovered a genetic mutation that is responsible for lack of ovary development. To date, very few genes have been identified that are important to ovarian formation and fertility and little is known about the processes involved in the development of the ovary or egg.

The discovery, which is expected to enable doctors to diagnose a cause of infertility and the absence of puberty, is a collaborative effort of Prof. David Zangen, head of Pediatric Endocrinology at Hadassah Hospital-Mount Scopus; Dr. Offer Gerlitz (Ph.D), Dept. of Developmental Biology and Cancer Research of the Hebrew University Faculty of Medicine’s Institute for Medical Research Israel-Canada; and Prof. Ephrat Levy-Lahad, Professor of Internal Medicine and Medical Genetics at Hebrew University and Director of the Medical Genetics Institute at Shaare Zedek Hospital in Jerusalem. The research is highlighted as the cover story in the November issue of the prestigious Journal of Clinical Investigation.

The mammalian ovary functions not only as the reproductive organ that contains the germ cells (oocytes) responsible for creating the next generation, but also as a hormonal gonad (reproductive gland) which regulates many aspects of female physiology and development. The researchers discovered a consanguineous family (descended from a common ancestor) where four female cousins presented with ovarian dysgenesis (a lack of ovarian development), despite the fact that each possesses two X chromosomes, as does a normal woman. Because these girls lacked sex hormones, they did not undergo the regular process of puberty. Rather, they were treated with replacement hormones, which allowed them to reach a normal height and to experience a monthly menstrual cycle.

When the researchers mapped the girls’ genomes and searched for regions of genetic commonality among them which were not shared by their healthy relatives, they identified a mutation in the gene, Nucleoporin 107 (Nup107). The researchers then searched for a model that would provide experimental proof that linked this mutation to the lack of ovarian development. They found their model in the fruit fly—Drosophila, generating flies with the mutation that was identical to the one found in the affected girls.

Many of the female flies, the study team found, demonstrated significant impairment in ovarian development. The remaining mutant female flies did lay eggs, but minimally, and the majority of the eggs were deformed to the point that they did not hatch and lead to reproduction.

Consequently, the model proved the involvement of the Nup107 gene mutation in ovarian dysgenesis. The laboratories of Profs. Zangen and Levy-Lahad identified the consanguineous family with ovarian dysgenesis and discovered the mutation and gene, while the laboratory of Dr. Gerlitz generated the disease's model in Drosophila.

“These results,” the authors explain, “indicate a pivotal role for NUP107 in ovarian development and suggest that nucleoporin defects may play a role in milder and more common conditions such as premature ovarian failure.”

The collaborative study was supported by grants from the United States Agency for International Development program for Middle East Regional Cooperation and the Israel Science  Foundation.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Nov 30 2016

Hadassah Teams Up with Spinal Cord Institute to Study Outcomes of Traumatic Injuries

The medical interventions and outcomes for Israelis with a spinal cord injury (SCI) will now be captured in the Rick Hansen SCI Registry (RHSCIR), thanks to the November 16th launch of a partnership between the Hadassah Medical Organization and the Rick Hansen Institute (RHI), a Canadian-based not-for-profit organization named after the paralympic athlete who suffered a severe spinal cord injury following a car accident.

READ MORE ›
alt_text

Thursday, Nov 17 2016

A Birthday Party in Hadassah’s PICU: Helping a Four-Year-Old Recover

Yehoshua "Shuki" Pepper was crossing a Jerusalem street with an older sibling when a car ran him over. He was rushed to Hadassah Hospital Ein Kerem's Pediatric Intensive Care Unit in fair condition, but he wasn't speaking and subsequent MRIs of his head injury were worrisome.

READ MORE ›
alt_text

Thursday, Nov 17 2016

Ethiopian Pre-Nursing Students: On the Way to Fulfilling a Dream

“I know that some people are fine with looking at a screen all day, but I know I need the human touch--to work with people. I want to be a nurse, " relates Sarah Talala, one of the 18 students of Ethiopian background who were given the opportunity to take a course which enabled them to advance to pre-academic studies at the Hebrew University and then on to nursing school at the Hadassah-Hebrew University Henrietta Szold School of Nursing.

READ MORE ›
alt_text

Monday, Nov 14 2016

Granalix BioTechnologies Introduces Food Additive to Protect Against Neurodegenerative Disease

Granalix BioTechnologies, whose founder and Chief Executive Officer is Hadassah Medical Organization Experimental Neurologist Prof. Ruth Gabizon, has launched a food supplement containing pomegranate oil that has proven to protect against neurodegenerative diseases in pre-clinical models.

READ MORE ›

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Membership Questions

membership@hadassah.org

(800) 664-5646

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Missions Department

missions@hadassah.org

(800) 237-1517

Show More